IP Library Granted Patent US 7,884,182
Granted Patent B2
US 7,884,182 · App. 10/494,928 · Granted Feb 8, 2011

Chemical peptide ligation with three or more components

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,884,182
App. No.
10/494,928
Granted
Feb 8, 2011
Kind
B2
Abstract

The invention provides a method of assembling oligopeptide intermediates in a native chemical ligation reaction that eliminates self-ligation of bi-functional intermediates. An important aspect of the invention is a bi-functional intermediate with an N-terminal heterocyclic protecting group which effectively prevents self-ligation in the chemical assembly process. The present invention is useful in methods for convergent synthesis of polypeptides and proteins and improves the efficiency of native chemical ligation reactions, particularly where three or more peptide fragments are used to assemble a polypeptide or protein product.

Claims (30)

1. A composition of matter comprising

an N-terminal heterocyclic-protected oligopeptide thioester defined by the following formula:

wherein:

each of Xaa 1 to Xaa n , is independently a protected or unprotected amino acid;

n is an integer from 2 to 120;

R 1 is hydrogen;

R 2 is hydrogen, unsubstituted alkyl having from 1 to 3 carbon atoms or an electron withdrawing-substituted alkyl having from 1 to 3 carbon atoms, said electron withdrawing substituent-selected from the group consisting of: halo, cyano, nitro-substituted alkyl having from 1 to 3 carbon atoms, carbonyl, carboxy, carboxyester, carboxyamide, amidocarboxy, amidocarbonyl, sulfoxy, sulfone and quartenary ammonium salts,

wherein R 2 may optionally be attached to a solid support;

R 3 is hydrogen or an electron donating group having from 1 to 12 carbon atoms and from 0 to 4 heteroatoms selected from the group consisting of nitrogen, oxygen, sulfur, and phosphorus;

R 4 is hydrogen, alkyl having from 1 to 3 carbon atoms, aryl or electron donating-substituted aryl having 6-10 carbon atoms with 0-2 heteroatoms, or electron donating-substituted alkyl having from 1 to 3 carbon atoms;

R 6 is alkyl having from 1 to 6 carbon atoms, alkylaryl having from 6 to 8 carbon atoms, —CH 2 —CONH 2 , —CH 2 CH 2 CONH 2 , or —(CH 2 ) k —CO—Xaa, wherein k is an integer equal to 1 or 2 and Xaa is an amino acid; and

R 9 is a side chain of an amino acid selected from the group consisting of alanine, aspartic acid, glutamic acid, phenylalanine, glycine, histidine, lysine, leucine, methionine, asparagine, glutamine, arginine, serine, tryptophan, and tyrosine.

2. The composition of claim 1 wherein:

R 3 is hydrogen, or a group having from 1 to 8 carbon atoms and from 0 to 2 heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur;

R 4 is hydrogen; and

R 9 is a side chain of an amino acid selected from the group consisting of glycine, alanine, and histidine.

3. The composition of matter according to claim 1 , wherein n is an integer from 2 to 70.

4. The composition of claim 3 wherein:

R 3 is hydrogen, phenyl, substituted phenyl, 2-picolyl, 4-picolyl, substituted 2-picolyl, or substituted 4-picolyl;

R 4 is hydrogen; and

R 9 is a side chain of an amino acid selected from the group consisting of glycine, alanine, and histidine.

5. The composition of claim 4 wherein R 3 taken alone is hydrogen or methoxy-substituted phenyl.

6. The composition of claim 3

wherein

R 2 is electron withdrawing-substituted alkyl having from 1 to 3 carbon atoms.

7. The composition of claim 3

wherein

R 2 is hydrogen,

R 3 is 4-methoxyphenyl, and

R 4 is hydrogen.

Assignments (5)
AMYLIN PHARMACEUTICALS, LLC ASSIGNS AN EQUAL AND UNDIVIDED ONE-HALF OF ITS ENTIRE RIGHT, TITLE AND INTEREST TO ASTRAZENECA PHARMACEUTICALS LP Recorded Oct 26, 2012
From: AMYLIN PHARMACEUTICALS, LLC
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 029195/0555 →
CHANGE OF NAME Recorded Oct 25, 2012
From: AMYLIN PHARMACEUTICALS, INC.
To: AMYLIN PHARMACEUTICALS, LLC
Reel/Frame 029198/0340 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2007
From: GENEPROT, INC.
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 018916/0006 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2007
From: GENEPROT, INC.
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 018916/0122 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2004
From: BOTTI, PAOLO; GAERTNER, HUBERT; MANGANIELLO, SONIA; VILLAIN, MATTEO
To: GENEPROT, INC.
Reel/Frame 015248/0072 →